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Background: Dual imaging stress echocardiography, combining the evaluation of wall motion and coronary flow
reserve (CFR) on the left anterior descending artery (LAD), and computed tomography coronary angiography
(CTCA) are established techniques for assessing prognosis in chest pain patients. In this study we compared the
prognostic value of the two methods in a cohort of patients with chest pain having suspected coronary artery
disease (CAD).
Methods: A total of 131 patients (76 men; age 68 ± 9 years) with chest pain of unknown origin underwent
dipyridamole (up to 0.84 mg/kg over 6 min) stress echo with CFR assessment of LAD by Doppler and CTCA. A
CFR ≤ 1.9 was considered abnormal, while > 50% lumen diameter reduction was the criterion for significant CAD at
CTCA.
Results: Of 131 patients, 34 (26%) had ischemia at stress echo (new wall motion abnormalities), and 56 (43%) had
reduced CFR on LAD. Significant coronary stenosis at CTCA was found in 69 (53%) patients. Forty-six patients (84%)
with abnormal CFR on LAD showed significant CAD at CTCA (p < 0.001). Calcium score was higher in patients with
reduced than in those with normal CFR (265 ± 404 vs 131 ± 336, p = 0.04). During a median follow-up of 7 months (1st
to 3rd quartile: 5–13 months), there were 45 major cardiac events (4 deaths, 11 nonfatal myocardial infarctions, and 30
late [≥6 months] coronary revascularizations). At Cox analysis, independent prognostic indicators were calcium
score > 100 (HR 2.84, 95% CI 1.33-6.07, p = 0.007), significant CAD at CTCA (HR 2.68, 95% CI 1.23-5.82, p = 0.013),
and inducible ischemia or CFR <1.9R on LAD on dual imaging stress echo (HR 2.25, 95% CI 1.05-4.84, p = 0.038).
Conclusions: Functional and anatomical evaluation using, respectively, dual imaging stress echocardiography
and CTCA are both effective modalities to risk stratify patients with chest pain of unknown origin, yielding
independent and comparable prognostic value. Compared to CTCA, however, stress echocardiography has the
advantage of lower cost and of being free of radiations.
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Dual imaging of wall motion and coronary flow reserve
(CFR) in the left anterior descending coronary artery
(LAD) is the current state-of-the-art technique for vaso-
dilator stress echocardiography [1] providing superior
diagnostic [2-7] and prognostic [8-10] value compared
to standard stress testing. In particular, a reduced CFR in
the LAD added prognostic information over wall motion
analysis in patients with known or suspected coronary
artery disease (CAD) [8]. Interestingly, the prognostic
capability of CFR was not affected by ongoing anti-
ischemic therapy [11,12].
Computed tomography coronary angiography (CTCA)
has emerged as a noninvasive effective diagnostic im-
aging modality [13-16], providing good correlation with
invasive measurement of stenosis severity [17]. In par-
ticular, CTCA demonstrated high accuracy and negative
predictive value in patients referred for chest pain of un-
known origin [17]. Unfortunately, CTCA provides a
non-negligible radiation exposure with associated cancer
risk [18,19]. In addition, it is unable to assess the
hemodynamic meaning of vessel stenosis, as fewer than
half of CTCA identified obstructive lesions confirmed by
coronary angiography cause ischemia [20].
This prospective, observational study was aimed at
assessing the prognostic value of dual imaging dipyrid-
amole stress echocardiography and CTCA in a cohort of
chest pain patients having suspected CAD.Methods
Study patients
From 2008 to 2010, 138 chest pain patients were pro-
spectively enrolled at the Cardiology Division, Umberto
I Hospital, Mestre, fullfilling the following inclusion cri-
teria: [1] stable chest pain syndrome; 2) no history of
CAD (i.e., history of myocardial infarction, coronary re-
vascularization, and/or angiographic evidence of > 50%
diameter coronary stenosis); 3) adequate image quality
allowing satisfactory wall motion analysis and LAD
flow; 4) no significant valvular heart disease; 5) no co-
morbidity reducing life expectancy to < 1 year. Of the
138 initially selected patients, 7 were lost to follow-up.
Thus, 131 patients (76 men; age 68 ± 9 years) formed
the study group.
The study was approved by the institutional review
board of Dell’Angelo Hospital Mestre-Venice Italy. All
patients gave their written informed consent before
undergoing stress echocardiography. When patients
signed the written informed consent they also autho-
rized physicians to use their clinical data according to
Italian law. All patients were followed-up for a median
of 9 months, with a minimum pre-defined follow-up
time of 6 months.Resting and stress echocardiography
Transthoracic stress echocardiographic studies were per-
formed with a commercially available ultrasound ma-
chine (iE 33, Philips Ultrasound, Andover, MA, USA)
equipped with multifrequency phased-array sector scan
probes (S3 to S8) and with second harmonic technology.
Two-dimensional echocardiography and 12-lead electro-
cardiographic monitoring were performed in combin-
ation with high-dose dipyridamole (up to 0.84 mg over
6 min). Echocardiographic images were semiquantita-
tively assessed using a 17-segment, 4-point scale model
of the left ventricle [1]. A wall motion score index was
derived by dividing the sum of individual segment scores
by the number of interpretable segments. Ischemia was
defined as stress-induced new and/or worsening of pre-
existing wall motion abnormality. Wall motion abnor-
mality at rest was akinetic or dyskinetic myocardium
with no thickening during stress. CFR was assessed dur-
ing standard stress echocardiographic examination by
intermittent imaging of wall motion and LAD flow [1].
Coronary flow in the mid-distal portion of the LAD was
searched in the low parasternal long-axis section under
the guidance of color Doppler flow mapping [1,2,7]. All
studies were digitally stored to simplify off-line reviewing
and measurements. Coronary flow parameters were ana-
lyzed off-line using the built-in calculation package of
the ultrasound unit. Flow velocities were measured 2
times for each study, namely at baseline and at peak
stress (before aminophylline injection). At each time
point, three optimal profiles of peak diastolic Doppler
flow velocities were measured, and the results were aver-
aged. CFR was defined as the ratio between hyperemic
peak and basal peak diastolic coronary flow velocities.
Images were digitally stored at rest, at peak dipyridamole
stress testing, and after aminophylline infusion [7]. A
CFR on LAD < 1.9 was taken as abnormal [21]. Quality
control of stress echocardiographic performance was
previously described in depth [22]. Previously assessed
intra- and interobserver variabilities for measurements
of Doppler recordings and regional wall motion analysis
assessment were < 10% [2].
CT coronary angiography
Heart rate was controlled by intravenous beta blockers,
usually metoprolol, administered before CTCA with a
titration dose up to 20 mg in patients with heart rate 65
beats/min. In all patients, CTCA was performed using a
64-slice scanner (64 × 0.625 mm collimation, 330 ms gan-
try rotation time, VCT, GE Medical Systems, Milwaukee,
WI, USA). Dose modulation was attained with “electrocar-
diographic gating” for a maximum gantry delivery between
40% and 80% during the R-R interval. A bolus of 80 ml of
high-concentration contrast (Iomeron 400 mg/ml, Bracco
Imaging, Milan, Italy) was administered intravenously at
Table 1 Baseline characteristics of the patients
Age (years) 68 ± 9
Male gender (%) 83 (63%)
Smoke (%) 34 (26%)
Diabetes (%) 29 (27%)
Hypertension (%) 71 (54%)
Dyslipidemia (%) 77 (59%)
LV ejection fraction at rest (%) 56 ± 6
WMSI at rest 1.07 ± 0.16
Mean CFR on LAD (cm/s) 2.12 ± 0.58
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fusion rate. The scan was initiated according to the bolus-
tracking technique. The coronary calcium score was
assessed with dedicated software (CaScore Package, GE
Healthcare, Milwaukee, WI, USA), and Agatston score was
recorded.
A calcium score > 100 was considered significant
[23-25].
Image datasets were analyzed using volume rendering
and multiplanar reconstruction on post-processing
workstations (CardioQ3 package, Advantage Worksta-
tion version 4.2, GE Healthcare) [23]. A semiquantitative
scale was used by the CCTA readers to grade extent of
luminal stenosis as a percentage of the vessel diameter
using visual estimations.
A vessel stenosis ≥ 50% in at least one coronary artery
was the criterion for CAD at CTCA. CTCA and dipyrid-
amole stress echocardiography data were collected and
analyzed by different observers. The imaging data were
accessible to the referring physician (FR).
Follow-up data
Outcome was determined from patient interviews at
outpatient clinics, hospital chart reviews, and telephone
interviews with a patient, a patient’s close relative, or
referring physician. Clinical events recorded during
follow-up were death, nonfatal myocardial infarction,
early (<6 months) and late (≥6 months) coronary revas-
cularization (surgery or angioplasty). To avoid misclassi-
fication of cause of death, overall mortality was
considered. The diagnosis of acute myocardial infarction
was made on the basis of symptoms, ECG changes, and
cardiac enzyme level increases. Late revascularization
was considered as clinical end-point, reflecting new or
progressive symptoms. The data were analyzed for the
prediction of major events (death, infarction, late
revascularization).
Statistical analysis
Data were expressed as mean ± standard deviation for
continuous variables and as numbers (percent) for cat-
egorical variables. Continuous variables were compared
using the Student’s unpaired t-test, while differences of
categorical variables were assessed by the chi-square test.
Linear regression was adopted to assess the correlation
between calcium score and peak and rest-stress wall mo-
tion score index Kaplan-Meier curves were used for esti-
mation of event rate. Only the first event was taken into
account. Patients undergoing coronary revascularization
were censored at the time of the procedure. The associ-
ation of selected variables with outcome was assessed
with the Cox proportional hazard model using univariate
and stepwise multivariate procedures. A significance of
0.05 was required for a variable to be included in themultivariate model, and 0.1 was the cut-off value for ex-
clusion. Hazard ratios with corresponding 95% confi-
dence intervals were estimated. Statistical significance
was set at p < 0.05.
SPSS 16.0 (SPSS, Inc., Chicago, IL, USA) was used for
analysis.Results
The clinical and echocardiographic characteristics of the
study group are shown in Table 1. Of 131 patients, 34
(26%) had ischemia at stress echocardiography, and 56
(43%) had impaired CFR on LAD. A significant CAD at
CTCA was documented in 69 (53%) cases.
Calcium score was higher in patients with reduced than
in those with normal CFR on LAD (265 ± 404 vs 131 ±
336, p = 0.04). In particular, patients with reduced CFR on
LAD showed higher percentage of calcium score >100,
compared to those with normal CFR on LAD (32/55 pts,
58% vs 17/76 pts, 22%, p < 0.001).
In addition, calcium score significantly correlated
withwall motion score index at peak stress (r = 0.222,
p = 0.011) and rest-stress change in wall motion score
index (r =0.225, p = 0.010). A calcium score >100 was
observed in 25 of 34 patients with stress-induced
ischemia and in 24 of 97 patients with no ischemia
(74 vs 25%, p < 0.001).
CFR on LAD was also found to correlate with the pres-
ence of CAD at CTCA. Indeed, CAD at CTCA was evi-
denced in 46 of 55 patients with reduced CFR and in 26 of
76 patients with normal CFR (84 vs 34%, p < 0.001).
During a median follow-up of 7 months (1st to 3rd
quartile: 5–13 months), 45 major cardiac events (4
deaths, 11 nonfatal myocardial infarctions, and 30 late
coronary revascularizations) were registered. Additionally
Ciampi et al. Cardiovascular Ultrasound  (2015) 13:21 Page 4 of 719 patients underwent early revascularization and were
excluded from outcome analysis.
At Cox analysis, calcium score > 100 (HR 2.84, 95% CI
1.33-6.07, p = 0.007), significant CAD at CTCA (HR 2.68,
95% CI 1.23-5.82, p = 0.013), and presence of inducible is-
chemia and/or reduced CFR on LAD (HR 2.25, 95% CI
1.05-4.84, p = 0.038) (Table 2) were multivariable prognos-
tic indicators. The event rate was markedly (p < 0.0001)
lower for patients with no ischemia and normal CFR on
LAD, calcium score < 100, or no CAD at CTCA (Figure 1).Discussion
In patients with chest pain and suspected CAD, func-
tional dual imaging-derived parameters such as inducible
ischemia or reduced CFR on LAD and significant CAD
at CTCA as well as vessel calcification provide strong
and comparable prognostic information.Anatomic evaluation of coronary stenosis: CTCA
CTCA is a recognized modality for the non-invasive as-
sessment of CAD, with a reported mean sensitivity and
specificity >90% [26].
Calcium score adds prognostic value to that of trad-
itional risk factors [23-25]. Of note, it allows to reclassify
intermediate risk asymptomatic subjects in more accur-
ate risk categories [27,28]. In this study we found a dir-
ect relationship between high calcium score and the
presence of stress-induced ischemia or impaired CFR on
LAD. Moreover, high calcium score was an independent









Family history 1.164 (0.888-3.035
Therapy 1.542 (0.796-2.987
Ejection fraction 1.010 (0.965-1.058
Rest WMSI 0.716 (0.131-3.914
CFR on LAD ≤ 1.9 3.095 (1.139-8.410
Stress-induced Ischemia 3.997 (2.144-7.558
Stress-induced Ischemia or CFR on LAD ≤ 1.9 4.475 (2.261-8.854
Calcium score > 100 5.984 (3.088-11.59
CAD at CTCA 4.911 (2.333-10.33
CAD at CTCA: stenosis > 50% at least one coronary artery.Previous experiences on symptomatic unselected pa-
tient populations showed CTCA to be more accurate
than calcium score to predict all-cause mortality [29-31].
However, both obstructive and non-obstructive CAD at
CTCA was associated with increased mortality in the
Confirm study [32]. In addition, in stable patients with
suspected or known CAD, non-invasive fractional flow
reserve computed from CT was associated with im-
proved diagnostic accuracy and discrimination compared
to CTCA alone for diagnosis of hemodynamically
significant CAD [33].
Functional evaluation of coronary stenosis: stress
echocardiography
In recent years, dipyridamole stress echocardiography
with combined assessment of CFR in the LAD has entered
the echocardiography lab as a highly feasible technique
[7], providing additional diagnostic value over conven-
tional wall motion analysis [8-12,34]. In fact, dipyridamole
stress echocardiography with combined assessment of
CFR has also been extensively validated in its prognostic
correlates and has allowed effective risk assessment in dia-
betics with negative stress echocardiographic results by
wall motion criteria, [9], in subjects with intermediate
LAD stenosis [10], and in those with normal or near-
normal coronary arteries [11]. Interestingly enough, the
prognostic capability of CFR was not affected by ongoing
anti-ischemic therapy [12].
CFR on LAD or inducible wall motion abnormalities
would certainly improve the cost-benefit practice compared
with indiscriminate “carpet bombing” with dilatation for alle follow-up
is Multivariate analysis













) < 0.001 2.252 (1.047-4.842) 0.038
9) < 0.001 2.841 (1.329-6.075) 0.007
4) < 0.001 2.681 (1.234-5.823) 0.013
Figure 1 Kaplan-Meier survival curves for two different groups of
the patients based on calcium score (Ca-score)≥ 100 and Ca-score
< 100 (Up).Kaplan-Meier survival curves for two different groups of
the patients based on the presence (>50%) or absence of coronary
artery stenosis at CTCA of at least one coronary artery (in the medium).-
Kaplan-Meier survival curves for the two different groups of patients
based on abnormal CFR on LAD (≤1.9) and/or wall motion score index
change positive for stress-induced ischemia compared to patients with
normal CFR on LAD (>1.9) without stress-induced ischemia (Down).
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physiologic substrate. The American Heart Association/
American College of Cardiology/Society for Cardiovascular
Angiography and Interventions on percutaneous coronary
interventions guidelines and the American Heart Associ-
ation scientific statement from the committee on diagnostic
and interventional cardiac catheterization have indicated
that in the presence of an intermediate lesions, when frac-
tional flow reserve is < 0.75 or CFR is < 2.0, the stenosis is
considered hemodynamically significant and percutaneous
coronary intervention can be supported [35].
Accordingly, in this study we showed that CFR on
LAD or stress-induced ischemia were independent pre-
dictors of events, and higher coronary calcification score
was associated with lower values of CFR.
Clinical use of the techniques
The clinical use of stress echo and CTCA should consider
the cost, safety, effectiveness and feasibility issues that
may vary in the various centers since - for instance - the
radiation dose of CTCA may range from 1 to 30 mSv
depending upon type of technology, operator skills, and
clinical questions (calcium score vs coronary angiography)
[18,19]. Stress echocardiography has several advantages,
including the possibility of obtaining information on
regional function and CFR in the same sitting, low cost,
and radiation-free nature of the ultrasound technique.
Yet, it is dependent upon the skill and experience of the
reader and therefore not all centers have adequate expert-
ise to guarantee high diagnostic standards [7-12,34].
Study limitations
For uniformity of the study population, we enrolled all
patients with symptoms (patients with chest pain syn-
drome of unknown origin) without history of previous
myocardial infarction or previous myocardial revascu-
larization. This represents a group with intermediate
pre-test likelihood of disease, where the indication for
noninvasive testing is more appropriate [35].
In all patients, medical therapy was kept unchanged.
This may have caused suboptimal echo studies with false
negative results for wall motion analysis. However, the
prognostic capability of CFR on LAD is not affected by
ongoing therapy [12].
Conclusions
Dipyridamole stress echocardiography and CTCA are
two noninvasive methods providing different and poten-
tially complementary information on patients with chest
pain and suspected CAD, giving excellent risk stratifica-
tion. Both tests are valuable for risk stratification in
patients with chest pain and suspected CAD, however
stress echo is radiation free and has limited costs when
compared to CTCA.
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